Perrine Luigi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Anti-insulin antibodies (AIA) usually have no impact on glucose control in type 1 diabetes (1). However, high titers of AIA with low/medium affinity for insulinmay formunstable immune complexes resulting in high glucose variability (2). Corticosteroids, plasmapheresis, mycophenolate mofetil (3), and rituximab (4) have been tried to solve this issue. We(More)
  • 1